DK0635027T3 - Peptid T og beslægtede peptider til behandling af inflammation, herunder dissemineret sclerose - Google Patents

Peptid T og beslægtede peptider til behandling af inflammation, herunder dissemineret sclerose

Info

Publication number
DK0635027T3
DK0635027T3 DK93907942T DK93907942T DK0635027T3 DK 0635027 T3 DK0635027 T3 DK 0635027T3 DK 93907942 T DK93907942 T DK 93907942T DK 93907942 T DK93907942 T DK 93907942T DK 0635027 T3 DK0635027 T3 DK 0635027T3
Authority
DK
Denmark
Prior art keywords
absent
thr
ser
gly
treatment
Prior art date
Application number
DK93907942T
Other languages
Danish (da)
English (en)
Inventor
Anders Joergen Andersen
Peter Louis Carlen
Penelope Reed Doob
Douglas Kevin Macfadden
David James Phipps
Deborah Rathjen
Fred Widmer
Roger Aston
Original Assignee
Advanced Immunit T Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK92645A external-priority patent/DK64592D0/da
Application filed by Advanced Immunit T Inc filed Critical Advanced Immunit T Inc
Application granted granted Critical
Publication of DK0635027T3 publication Critical patent/DK0635027T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/549—Sugars, nucleosides, nucleotides or nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK93907942T 1992-03-27 1993-03-29 Peptid T og beslægtede peptider til behandling af inflammation, herunder dissemineret sclerose DK0635027T3 (da)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US85883292A 1992-03-27 1992-03-27
DK92645A DK64592D0 (da) 1992-05-14 1992-05-14 Peptider til terapeutisk behandling
US91511892A 1992-07-17 1992-07-17
US98767492A 1992-12-09 1992-12-09
PCT/GB1993/000649 WO1993020102A1 (en) 1992-03-27 1993-03-29 Peptide t and related peptides in the treatment of inflammation, including multiple sclerosis

Publications (1)

Publication Number Publication Date
DK0635027T3 true DK0635027T3 (da) 2000-10-02

Family

ID=27439352

Family Applications (2)

Application Number Title Priority Date Filing Date
DK99101349T DK0960886T3 (da) 1992-03-27 1993-03-29 Peptid T og beslægtede peptider til behandling af inflammation, herunder multipel sklerose
DK93907942T DK0635027T3 (da) 1992-03-27 1993-03-29 Peptid T og beslægtede peptider til behandling af inflammation, herunder dissemineret sclerose

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK99101349T DK0960886T3 (da) 1992-03-27 1993-03-29 Peptid T og beslægtede peptider til behandling af inflammation, herunder multipel sklerose

Country Status (12)

Country Link
EP (2) EP0960886B1 (uk)
JP (1) JP3520084B2 (uk)
KR (1) KR100312300B1 (uk)
AT (2) ATE194495T1 (uk)
AU (3) AU684713B2 (uk)
CA (1) CA2132516A1 (uk)
DE (2) DE69333537T2 (uk)
DK (2) DK0960886T3 (uk)
ES (2) ES2222625T3 (uk)
PT (1) PT960886E (uk)
UA (1) UA41881C2 (uk)
WO (1) WO1993020102A1 (uk)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5739109A (en) * 1988-12-16 1998-04-14 Advanced Immunit Inc. Method of treating neuroinflammatory degenerative diseases
US5795858A (en) * 1993-09-24 1998-08-18 Peptide Technology Limited Treatment or prevention of Crohn's disease and/or ulcerative colitis
WO1995008338A1 (en) * 1993-09-24 1995-03-30 Peptide Technology Limited Method for the treatment or prevention of eczema/dermatitis
IL149443A0 (en) * 1999-11-09 2002-11-10 Advanced Immuni T Inc Compositions for treating viral diseases
JP4611233B2 (ja) * 2005-04-06 2011-01-12 ニッタ株式会社 歩行訓練支援装置
US20140322251A1 (en) * 2013-04-26 2014-10-30 Michael Ruff Peptides for Progressive Treating Multi-Focal Leukoencephalopathy and Related Conditions
EP2832373B1 (en) * 2013-08-02 2017-04-12 Experimentelle Pharmakologie & Onkologie Berlin Buch Liposome for blocking site-specifically chemokine-related inflammatory processes in vascular diseases and metastasis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987007614A1 (en) * 1986-06-03 1987-12-17 Pert Candace B Small peptides which inhibit binding to t-4 receptors
NZ221440A (en) * 1986-08-20 1991-11-26 Genetic Systems Corp Composition containing monoclonal antibodies/peptides useful in treating and diagnosing hiv infections
AU1808088A (en) * 1987-05-22 1988-12-21 Syntbiotech, Inc. Synthetic peptides and a method of treating aids
WO1989012067A1 (en) * 1988-05-27 1989-12-14 The United States Of America, As Represented By Th Compositions having use as treatment of psoriasis and neuropsychiatric deficits
US5189022A (en) * 1988-05-27 1993-02-23 The United States Of America As Represented By The Secretary Of Health And Human Services Composition for the treatment of chronic fatigue syndrome

Also Published As

Publication number Publication date
ATE194495T1 (de) 2000-07-15
AU684713B2 (en) 1998-01-08
KR100312300B1 (ko) 2002-03-20
CA2132516A1 (en) 1993-10-14
ES2149203T3 (es) 2000-11-01
AU3895393A (en) 1993-11-08
EP0960886A1 (en) 1999-12-01
AU725680B2 (en) 2000-10-19
DK0960886T3 (da) 2004-09-27
ES2222625T3 (es) 2005-02-01
EP0960886B1 (en) 2004-05-26
AU6354298A (en) 1998-06-18
DE69329023D1 (de) 2000-08-17
AU2254999A (en) 1999-05-20
DE69329023T2 (de) 2001-03-22
KR950700931A (ko) 1995-02-20
PT960886E (pt) 2004-10-29
DE69333537T2 (de) 2005-06-16
EP0635027A1 (en) 1995-01-25
UA41881C2 (uk) 2001-10-15
EP0635027B1 (en) 2000-07-12
JPH07507061A (ja) 1995-08-03
ATE267838T1 (de) 2004-06-15
WO1993020102A1 (en) 1993-10-14
JP3520084B2 (ja) 2004-04-19
DE69333537D1 (de) 2004-07-01
AU718442B2 (en) 2000-04-13

Similar Documents

Publication Publication Date Title
SE9100799L (sv) Rekombinant derivat av human faktor viii
DE59007517D1 (de) Neue proteine mit tnf-hemmender wirkung und ihre herstellung.
ATE108662T1 (de) Antimikrobielle peptide, zusammensetzungen, die diese enthalten, und verwendungen daraus.
ATE171712T1 (de) Neuartiger menschlicher proteaseinhibitor vom kunitz-typ und entsprechende varianten
ATE209215T1 (de) Protegrine
DK0635027T3 (da) Peptid T og beslægtede peptider til behandling af inflammation, herunder dissemineret sclerose
DK31991D0 (da) Peptid og farmaceutisk praeparat indeholdende et saadant peptid
RU94027578A (ru) Фармацевтическая композиция и способ лечения рассеянного склероза
CA2006087A1 (en) Polypeptides isolated from the venom of the spider hololena curta
WO2001027136A3 (fr) Peptides ayant une activite de stimulation de la reponse immunitaire et de regeneration tissulaire
DE69232698T2 (de) Neuer megakaryocyten-verstärker
KR950702573A (ko) 공유결합된 항산화제를 갖는 합성 펩티드 폐 계면활성제(Synthetic Peptide Lung Surfactants Having Covalently Bonded Antioxidants)
ATE3773T1 (de) An peptide polymerisationsprodukte gebundene muramyl-peptide und sie enthaltende pharmazeutische zusammensetzungen.
IL102615A (en) Immunoassy kit for simultaneously detecting antibodies to hiv-1, hiv-2, htlv-1 and htlv-ii and methods for te detections of antibodies
RU94046096A (ru) Линейные или циклические пептиды, их применение, способы лечения и конъюгаты пептидов
ATE425988T1 (de) Peptide mit affinitat fur ein phospholipid und deren verwendung